Skip to search formSkip to main contentSkip to account menu

HSR-903

Known as: HSR 903 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

olamufloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice.
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin… 
2000
2000
Susceptibilities of Neisseria gonorrhoeae Isolates Containing Amino Acid Substitutions in GyrA, with or without Substitutions in ParC, to Newer Fluoroquinolones and Other Antibiotics
ABSTRACT We examined the antimicrobial susceptibilities of 85Neisseria gonorrhoeae isolates, classified according to the presence… 
1999
1999
Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
The distribution of HSR-903, a new quinolone antibacterial agent, to the brain after i.v. administration to rats was low compared… 
1999
1999
Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent.
HSR-903 [(S)-(-)-5-amino-7-(7-amino-5-azaspiro[2. 4]hept-5-yl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methyl-4-oxoquinoline-3… 
1999
1999
Tissue selective drug delivery utilizing carrier-mediated transport systems.
1998
1998
Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
HSR-903 is a newly synthesized quinolone antibacterial agent with low toxicity. The biliary and urinary excretion of unchanged… 
1998
1998
In Vivo Activity of HSR-903, a New Fluoroquinolone, against Respiratory Pathogens
ABSTRACT The in vivo activity of HSR-903, a new fluoroquinolone, against major bacteria which cause respiratory tract infections… 
1997
1997
In vitro activity of HSR-903, a new quinolone
The in vitro activity of the new fluoroquinolone HSR-903 was compared with those of ciprofloxacin, lomefloxacin, sparfloxacin… 
1997
1997
In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic
The in vitro and in vivo antichlamydial activities of HSR-903 were investigated. The MICs of HSR-903 for different species of… 
1997
1997
In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.
The in-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, was tested against 51 clinical Neisseria gonorrhoeae… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)